Table 2.
Level | Physiological variables | Symptom status | Functional status | Health perceptions | Health related quality of life | |||
---|---|---|---|---|---|---|---|---|
Model | I MRC | II FVC | III FSS | IV RHS | V EQ-5D VAS | VI MCS | VII PCS | VIII Utility |
Constant | 83.452 | 70.526 | 8.737 | 16.989 | −9.313 | 49.990 | 24.526 | 0.530 |
Age | −0.069 | −0.144 | 0.011 | −0.096 | 0.126 | −0.016 | −0.046 | 0.001 |
Female | −0.028 | 17.994 | 0.307 | −0.957 | 4.673 | −1.282 | −0.402 | 0.010 |
Disease duration | −0.563 | −0.346 | −0.077 | −0.052 | 0.653 | 0.063 | −0.086 | −0.001 |
Enzyme activity | 0.370 | −0.431 | 0.007 | −0.048 | 0.004 | −0.359 | −0.069 | −0.006 |
Muscle strength | −0.031 | 0.189 | ||||||
Respiratory function | −0.011 | 0.075 | ||||||
Fatigue Severity Scale | −0.578 | |||||||
Rotterdam Handicap Scale | 2.030 | |||||||
Visual Analogue Scale | 0.157 | 0.223 | 0.004 | |||||
patients | 78 | 72 | 61 | 61 | 73 | 73 | 73 | 71 |
observations | 249 | 257 | 160 | 158 | 154 | 152 | 152 | 161 |
R2 (overall) | 0.105 | 0.075 | 0.322 | 0.623 | 0.343 | 0.183 | 0.293 | 0.354 |
Wald test (p-value) | <0.001 | 0.001 | 0.002 | <0.001 | <0.001 | 0.005 | <0.001 | <0.001 |
Figures in bold indicate significance at 5 % level; Enzyme activity, muscle strength and respiratory function were measured as a percentage of normal values, Visual Analogue Scale, Mental Component Scale and Physical Component Scale were measured on a scale from 0–100, Fatigue Severity Scale was measured on a scale from 1–7, Rotterdam Handicap Scale was measured on a scale from 0–36, Utility was measured on a scale from 0–1